Table 2 Guideline adherence
Therapy | Prophylaxis | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
AMC | OLVG W | SLZ | Total | AMC | OLVG W | SLZ | Total | ||
Number of prescriptions | 266 | 157 | 124 | 547 | 98 | 42 | 33 | 173 | 720 |
Guideline available (%) | 249 (93.6) | 149 (94.9) | 122 (98.4) | 520 (95.1) | 96 (98) | 36 (85.5) | 32 (97) | 164 (94.8) | 684 (95) |
Guideline non-adherence (%) | 95 (38.2) | 84 (56.4) | 45 (36.9) | 224 (43.1) | 16 (16.7) | 7 (19.4) | 19 (59.4) | 42 (25.6) | 266 (38.9) |
No indication (%) | 17 (17.9) | 13 (15.5) | 10 (22.2) | 40 (17.9) | 15 (93.8) | 6 (85.7) | 18 (94.7) | 39 (92.9) | 79 (29.7) |
Inappropriate agent (%) | 31 (32.6) | 37 (44) | 24 (53.3) | 92 (41.1) | – | – | – | – | 92 (34.5) |
Inappropriate dose/duration (%) | 47 (49.5) | 34 (40.5) | 11 (24.4) | 92 (41.1) | 1 (6.3) | 1 (14.3) | 1 (5.3) | 3 (7.1) | 95 (35.7) |